Home » Plenary Sessions » Page 36

From Plenary Sessions

CND Day 1 – Agenda item 6(a): Challenges and future work of the CND and the WHO in the review of substances for possible scheduling recommendations

The goal is to assist states in applying the procedures as outlined in the three drug conventions. E/CN.7/2014/10 outlines the relevant provisions of the drug control conventions for scheduling. UNODC – By December 2014, the number of NPS reported by NPS rose to over 540 substances. The global spread of these substances have also increased …

Read more

CND Day 1 – Agenda item 6(b): Change in the scope of control of substances

Commission will identify the notifications in the order they were received. Begin with mephedrone recommended by the UK. Then will look at ketamine recommended by China. Then will look at reocmmendations from the WHO including (a) AH-7921 should be placed in Schedule I of the 1961 Convention; (b) gamma-Butyrolactone (GBL), 1,4-butanediol, 25B-NBOMe (2C-B-NBOMe), 25C-NBOMe (2C-C-NBOMe) …

Read more

CND Day 4 – VNGOC statement

We have evidence based interventions which can greatly increase effectiveness of prevention, early intervention, harm reduction, treatment and recovery. But little evidence these are implemented. Evidence of strategies, but not of resources and implementations. We have evidence base, limited which need to be improved across 3 pillars of plan of action. Debate on effective drug …

Read more